Mabpharm Limited — Audit Report / Information 2018

May 17, 2019

PHIP

	Mabpharm Limited
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

 

	Warning Statement
	Important
	Expected Timetable
	Contents
	Summary
	Definitions
	Glossary
	Forward-looking Statements
	Risk Factors
	Waivers from Strict Compliance with the Listing Rules and Exemptions from Strict Compliance with the Companies (Winding Up and Miscellaneous Provisions) Ordinance
	[REDACTED]
	Directors and Parties Involved in the [REDACTED]
	Corporate Information
	Industry Overview
	Regulatory Overview
	History, Development and Corporate Structure
	Business
	Financial Information
	Directors and Senior Management
	Relationship with the Controlling Shareholders
	Connected Transactions
	Share Capital
	Substantial Shareholders
	[REDACTED]
	Future Plans and [REDACTED]
	[REDACTED]
	[REDACTED]
	[REDACTED]
	Appendix I: Accountants’ Report
	Appendix II: Unaudited Pro Forma Financial Information
	Appendix III: Summary of the Constitution of the Company and Cayman Islands Company Law
	Appendix IV: Statutory and General Information
	Appendix V: Documents Delivered to the Registrar of Companies and Available for Inspection